CAXTON CORP
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Portfolio style
Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.
Closest benchmark: the S&P 500 as of 2026-06-30, active share 92.6%; sector active share 51.9% against the combined 13F book's sector weights.
Over time 26 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
10 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Portfolio Trend
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Financial Services | 30.5% | $565,212 |
| Industrials | 24.0% | $445,261 |
| Healthcare | 19.6% | $362,737 |
| Communication Services | 13.3% | $246,942 |
| Unclassified | 12.6% | $232,828 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | −6,426 | 12,347 | $110,011 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterSold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| GLD | Spdr Gold Trust | 7,623 | $3,280,100 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SPCX |
Space Exploration Technologies Corp
Industrials
|
NEW | 2,606 | $445,261 | 24.03% | |
| BRK-B |
Berkshire Hathaway Inc
Financial Services
|
Added | 754 | $377,294 | 20.36% | |
| GOOGL |
Alphabet Inc.
Communication Services
|
NEW | 691 | $246,942 | 13.33% | |
| VOO |
VANGUARD 500 INDEX FUND
|
NEW | 339 | $232,828 | 12.57% | |
| BX |
Blackstone Inc.
Financial Services
|
NEW | 1,597 | $187,918 | 10.14% | |
| KYTX |
Kyverna Therapeutics, Inc.
Healthcare
|
Reduced | 12,347 | $110,011 | 5.94% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
Added | 16,962 | $78,958 | 4.26% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Held | 15,557 | $72,651 | 3.92% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
Held | 28,453 | $57,759 | 3.12% | |
| ALXO |
Alx Oncology Holdings Inc
Healthcare
|
Held | 20,946 | $43,358 | 2.34% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.